This page features ACC's full meeting coverage of the latest science from ACC.24 – including trial summaries, news stories, journal scans, videos and more.

YOU ARE HERE: Home > Guidelines and Clinical Policy > Guidelines Search ...

Regardless of your interests, level of experience or professional role—ACC has an option for you to get involved. Whether you have a few minutes a month or few hours a week, you can shape the future ...

The Diabetes and Cardiometabolic Disease Clinical Topic Collection gathers the latest guidelines, news, JACC articles, education, meetings and clinical images pertaining to its cardiovascular topical ...

This page features ACC's full coverage of the latest science from American Heart Association's (AHA) Scientific Sessions 2025, taking place Nov. 7–10 in New Orleans, LA.

We have detected a security warning. If you feel this message may be in error, please notify us and reference the following support ID: a9c48fdb-34b9-4ec7-95a4-cb1224e2b87f ...

Using the European Society of Cardiology (ESC) 0/1-hour high-sensitivity troponin (hs-cTn) accelerated diagnostic pathway (ADP) did not result in significantly more patients being discharged within ...

The U.S. Food and Drug Administration (FDA) has approved baxdrostat, a first-in-class oral aldosterone synthase inhibitor, as an add-on therapy for hypertension in adults whose blood pressure (BP) is ...

In his Editor's Page Harlan M. Krumholz, MD, SM, MACC, discusses what he calls the "most important unsolved problem" with treating dyslipidemia. "Too many patients who could benefit greatly are not ...

We have detected a security warning. If you feel this message may be in error, please notify us and reference the following support ID: 9c768110-84e1-447b-b2b8-83cf089cbbb5 ...

Login to subscribe for notifications.

This CardiaCast episode explores the latest advances in transthyretin amyloid cardiomyopathy (ATTR-CM) presented at ACC.26, with a focused review of newly released late-stage clinical trial data for ...